Srinivasarao, Madduri
Galliford, Chris V.
Low, Philip S.
Article History
First Online: 20 February 2015
Competing interests
: P.S.L. owns shares in Endocyte, which develops small-molecule drug conjugates using the folate-targeting technology discussed in the article. M.S. and C.V.G. declare no competing interests.